[Rattlesnake bite poisoning, health damage and treatment in children]

Norberto Sotelo-Cruz1

  • 1Hospital Infantil del Estado de Sonora, Reforma Norte 355, Colonia Ley 57, 83100, Hermosillo, Sonora.

Gaceta Medica De Mexico
|October 25, 2003
PubMed

Insights

A revised pediatric rattlesnake bite protocol in Mexico significantly reduced hospital stays from 15 to 5 days. This updated treatment sequence effectively minimized complications and lowered healthcare costs for children.

Area of Science:

  • Toxicology
  • Pediatric Medicine
  • Herpetology

Context:

  • Rattlesnake bites pose a significant health threat in Mexico, particularly in the pediatric population, with limited data on incidence and impact.
  • Crotalus atrox venom is a common cause of severe envenomation, frequently affecting lower extremities.

Purpose:

  • To present findings from a follow-up study of 55 pediatric patients treated for rattlesnake bites.
  • To propose an optimized therapeutic protocol for managing rattlesnake envenomations in children.

Summary:

  • A retrospective review of clinical records identified key variables including patient demographics, bite circumstances, and treatment outcomes.
  • The study highlights that 50% of patients received inadequate antivenom doses prior to hospital admission, with hematologic complications occurring in 69% of cases.
  • One fatality was recorded due to multiple organ failure and disseminated intravascular coagulation (DIC).

Impact:

  • The implemented and revised treatment protocol, in use since 1986, has demonstrably reduced hospital stays from 15 to 5 days.
  • The protocol has proven effective in preventing further complications and has contributed to a favorable reduction in treatment costs.
Abstract

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Rabies01:28

Rabies

Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...